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Abstract 
Pulmonary perfusion disorders provoke atelectasis in order to minimize ventilation/perfusion 
mismatch. However, the underlying mechanisms remain unknown. Because intraalveolar CO2 
concentration ([CO2]iA) declines as a consequence of poor pulmonary perfusion we postulated 
the existence a novel alveolar CO2-sensing mechanism which adapts the ventilation to 
perfusion. Real-time fluorescence imaging of rat lungs revealed that low [CO2]iA decreased 
cytosolic and increased mitochondrial Ca2+ in alveolar epithelial cells (AEC), leading to 
reduction of surfactant secretion and alveolar ventilation. Mitochondrial inhibition by 
ruthenium red or rotenone blocked the hypocapnia-induced responses. In cultured Type 2 
AEC hypocapnia decreased cytosolic Ca2+ independently from pH and increased the NADH 
production, the mitochondrial transmembrane potential (ΔΨ), and subsequently the 
mitochondrial Ca2+ uptake. All responses were completely blocked by the gene knockdown of 
the NADH producing Krebs cycle enzyme isocitrate dehydrogenase. Furthermore, ligature of 
the pulmonary artery of rabbits decreased alveolar ventilation, surfactant secretion, and lung 
compliance. Addition of 5% CO2 to the inspiratory gas inhibited all responses. Accordingly, 
we provide evidence for a novel CO2-sensing mechanism of AEC regulated by the Krebs 
cycle activity in terms of a negative feedback loop adapting surfactant secretion and thus 
regional ventilation to pulmonary perfusion. 
 
Keywords: alveolar carbondioxide sensing, calcium, surfactant secretion, mitochondria, 
regional ventilation 
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Introduction 
 
The mismatch between alveolar ventilation and perfusion is a typical complication in 
critically ill patients and results in gas exchange failure and reduction of oxygen delivery to 
systemic circulation. 
Ventilation disorders, as seen in pneumonia or atelectasis, are associated with regional 
alveolar hypoxia which evokes vasoconstriction of the pulmonary arteries. This well known 
response is termed hypoxic pulmonary vasoconstriction (HPV) and shifts as a compensatory 
mechanism blood from poorly to better ventilated lung segments, thereby reducing shunt 
fraction and optimizing gas exchange. 
Perfusion disorders occurring during pulmonary artery embolism or systemic inflammation 
with intravascular coagulation cause a reduction of ventilation in poorly perfused lung 
segments. This response seems to be a mechanism that opposes HPV and was first described 
in 1934 by Moore, Humphreys and Cochrane. They showed that in dogs an occlusion of the 
left pulmonary artery leads to a ventilation reduction of the ipsilateral lung with 
simultaneously ventilation increase in the contralateral lung 1. Occluding the right pulmonary 
artery induced a ventilation shift from right to left lung. Venrath et al. were able to 
demonstrate in 1952 the same ventilation shift in dogs using bronchospirometry 2. Swenson 
and co-workers published similar results in 1961 after pulmonary artery occlusion in patients 
using a balloon catheter 3.  
Although the perfusion-mediated regulation of ventilation has been described by several 
authors, the underlying mechanism has never been elucidated.  
Ventilation, at least in part, is regulated by surfactant which is secreted from Type 2 cells by 
exocytosis of lamellar bodies (LB). Secreted surfactant promotes alveolar opening by 
opposing the alveolar-collapsing tendency of air-liquid surface tension. LB exocytosis is 
triggered by an increase of cytosolic Ca2+ concentration ([Ca2+]cyt) in Type 2 cells, which 
results from direct effects of agonists or cell stretch 4-6. 
We considered that alveolar CO2 may play a crucial role in this scenario. Assuming that 
alveolar CO2 concentration drops in non-perfused but still ventilated alveoli the alveolar CO2 
concentration could signal whether the alveolus is being perfused. We therefore hypothesized 
that, in case of perfusion disorder, the decline of alveolar CO2 concentration initiates a 
reduction of ventilation by regulating LB exocytosis in order to normalize the ventilation-
perfusion ratio. 
CO2 measurement systems have been described for plants and questionably for the brain stem 
7, 8. However, a CO2-sensing mechanism of alveolar epithelial cells in order to regulate the LB 
exocytosis and thus ventilation to changes in perfusion by a Ca2+-signal transduction pathway 
is still unknown.  
In this context, the mitochondria require consideration. Mitochondria regulate [Ca2+]cyt by 
sequestering Ca2+ and releasing it to the cytosol 9-14. The mitochondrial accumulation of Ca2+ 
is facilitated by the Ca2+ uniporter which is located in the inner mitochondrial membrane 13. 
Ca2+ is stored inside the mitochondrial matrix in the form of osmotically inactive precipitates 
or is released back to the cytosol through the Ca2+/Na+ or Ca2+/H+ exchanger, which are also 
located on the inner membrane of the mitochondria 13. The driving force for mitochondrial 
Ca2+ uptake is the negative transmembrane potential gradient (ΔΨ) across the mitochondrial 
inner membrane 14. The membrane potential is component of the proton-motive gradient and 
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is set up through proton extrusion by the respiratory chain. Regulation of the respiratory chain 
activity and thus ΔΨ is complex. However, there are some indications that the rate of 
respiration can be stimulated by NADH. This respiratory chain substrate is produced in the 
Krebs cycle by the enzymes isocytrate dehydrogenase and α-ketoglutarate dehydrogenase 15-17 
together with CO2.  
It is a common effect that an accumulation of the product may inhibit whereas a rapid 
clearance of the product may accelerate its enzymatic reaction rate. We therefore hypothesize 
that a pulmonary perfusion failure induces a decrease of [CO2]iA which in turn increases the 
production of NADH and thus ΔΨ in AEC inducing a Ca2+-shift from the cytosol to the 
mitochondria. Furthermore, Kafta et al. have demonstrated that a Ca2+ shift into mitochondria 
abrogates increases of [Ca2+]cyt and subsequently diminishes Ca2+-dependent membrane 
exocytosis 18. However, the role of the Krebs cycle in CO2-sensing and surfactant secretion 
has not been described so far.  
Using fluorescence microscopy of the lung that enables in situ live imaging of intact alveoli 
we could describe for the first time that alveolar epithelial cells response to changes of 
[CO2]iA with a cytosolic Ca2+-signaling. In case of alveolar hypocapnia, as seen during 
pulmonary perfusion failure, Ca2+ is shifted from the cytosol to the mitochondria regulated by 
an increase of the Krebs cycle activity. In turn, surfactant secretion and alveolar ventilation is 
reduced in order to minimize ventilation/perfusion mismatch. Furthermore, using in vivo 
imaging of lung surface and a pulmonary artery ligature model we could demonstrate that 
CO2 admixed to the inspiratory gas inhibits the reduction of ventilation in non-perfused lung 
areas.
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Results 
 
CO2 regulates cytosolic calcium concentration [Ca2+]cyt in alveolar epithelial cells in situ. 
By means of alveolar micropuncture, we loaded alveolar epithelial cells with the Ca2+ 
fluorophore fura 2. The fura 2-loaded alveolus imaged as a circular fluorescent band that 
circumscribed a central nonfluorescent lumen. After establishing of alveolar hypocapnic 
conditions with an inspiratory CO2 fraction of 0% and with lung venous pCO2 of under 10 
mmHg, [Ca2+]cyt decreased in alveolar epithelial cells by 40±5 nM (mean±SE, p<0.05) versus 
baseline conditions within 10 minutes. This decrease was reversible after increasing the 
inspiratory CO2 fraction back to 5% and the pCO2 to normocapnic values. Hypercapnic 
alveolar conditions with an inspiratory CO2 fraction of 10% and pCO2 of 80 mmHg increased 
[Ca2+]cyt in alveolar epithelial cells by 45±3 nM (mean±SE, p<0.05). This increase was also 
reversible after lowering the inspiratory CO2 fraction and the pCO2 to normocapnic values 
(figure 1A-C).  
CO2 sensing is mitochondrial triggered in situ. To determine the role of mitochondria in the 
CO2-mediated calcium signaling we microinjected into the alveolus ruthenium red, an 
inhibitor of the mitochondrial Ca2+ uniporter, or rotenone, an inhibitor of the complex I of the 
respiratory chain. Pretreatment with ruthenium red inhibited the hypocapnia-induced decrease 
of [Ca2+]cyt by about 50%. Rotenone blocked the hypocapnia-induced calcium decrease 
completely (figure 1D). Under normocapnic conditions neither ruthenium red nor rotenone 
did affect fura 2 ratio. 
Furthermore, we microinjected into the alveolus rhod 2, a fluorescent dye for mitochondrial 
Ca2+ measurement, in combination with MTG for mitochondrial co-localisation (figure 2A). 
Hypocapnia induced an increase of rhod 2 fluorescence intensity equivalent for a rise of 
[Ca2+]mito (figure 2B). Taken together, these results indicate that the hypocapnia-induced 
decrease of [Ca2+]cyt was evoked by a calcium shift from the cytosol to the mitochondria 
mediated by the mitochondrial Ca2+ uniporter and complex I. 
Hypocapnia-dependent regulation of [Ca2+]cyt is pH-independent in vitro. In A549 cells 
the [Ca2+]cyt responses to hypo- or hypercapnia were equivalent to those in the isolated lung 
(figure 3A,B). To test whether the [Ca2+]cyt changes were induced rather by pH than CO2 we 
measured  in A549 cells the effect of CO2 on [Ca2+]cyt at a constant pH of 7.4. We could 
demonstrate that hypocapnia induced under constant extracellular pH of 7.4 similar reduction 
of [Ca2+]cyt as in unbuffered cells at a pH of 7.8 (figure 3B). In contrast, an alkalosis of 7.8 
under normocapnic conditions did not induce an alteration of [Ca2+]cyt. Furthermore, in 
unbuffered cells hypocapnia did not alter the cytosolic pH (figure 3D). We therefore conclude 
that the hypocapnia-induced [Ca2+]cyt responses were pH independent. 
Hypocapnia-induced cytosolic Ca2+ shift is mitochondrial ΔΨ-mediated in vitro. 
Suspecting that hypocapnia induces a Ca2+ shift from cytosol into mitochondria through an 
alteration of the mitochondrial membrane potential we loaded A549 cells with TMRM. 
Induction of hypocapnia at constant pH of 7.4 led to an increase of the ratio between the 
mitochondrial and cytosolic TMRM fluorescence intensity equivalent for increase of the 
mitochondrial ΔΨ (figure 4A,B). This response was blocked by rotenone (figure 4C,D). Since 
rotenone also inhibited the hypocapnia-induced decrease of [Ca2+]cyt (figure 1D), we conclude 
that hypocapnia induces a Ca2+ shift from cytosol into the mitochondrium through an increase 
of the mitochondrial membrane potential.   
Hypocapnia-induced increase of the mitochondrial ΔΨ and thus decrease of [Ca2+]cyt is 
NADH-mediated in vitro.  The Krebs cycle enzyme isocytrate dehydogenase (IDH) catalyzes 
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oxidative decarboxylation of isocitrate to α-ketoglutarate and requires NAD+, producing 
NADH.  In turn, NADH is utilised in the respiratory chain which is necessary to sustain the 
mitochondrial membrane potential. To elucidate whether hypocapnia induces an acceleration 
of the NADH production which in turn increases ΔΨ and subsequently provokes a Ca2+ shift 
from the cytosol to the mitochondria we downregulated the NADH producing IDH3G (figure 
4E). The decrease of [Ca2+]cyt and the increase of [Ca2+]mito or ΔΨ following hypocapnia at 
constant pH of 7.4 was detectible in native and scrambled siRNA-treated A549 cells (figure 
4F-H,A,B). However, all responses were completely absent in IDH3G downregulated cells 
(figure 4F-H,A,B). Additionally, in native cells hypocapnia increases the NADH-
concentration in comparison to normocapnia measured by the biochemical NADH assay 
(figure 4I). This increase was elevated after inhibition of the NADH consuming complex 1 
with rotenone (figure 4I). Furthermore, in control and scrambled siRNA-treated cells NADH 
autofluorescence increased following rotenone, which blocks the NADH consuming 
mitochondrial complex 1 (figure 4J,K). This increase was elevated upon induction of 
hypocapnia (figure 4J,K). In contrast, NADH fluorescence stayed stable following IDH3G 
gene knockdown (figure 4J,K). Taken together we conclude that under hypocapnic conditions 
Krebs cycle activity, NADH production, and thus ΔΨ increase and subsequently [Ca2+]cyt 
decreses independently from pH. 
CO2-mediated mitochondrial Ca2+ shift regulates surfactant secretion in situ. Figure 5A 
shows images of alveolar epithelial type II cells (AEC Type 2) after alveolar loading with 
LTG, a specific fluorescent dye for surfactant in the surfactant-storing lamellar bodies. Under 
normocapnic conditions LTG-intensity linearly decreased indicating a constant level of 
surfactant secretion. Hypocapnia induced an inhibition of the LTG fluorescence decrease 
indicating a reduction of surfactant secretion, whereas hypercapnia accelerates the decrease of 
the LTG fluorescence intensity and thus surfactant secretion in situ (figure 5B and C) within 
20 min. Hence, the rate of surfactant secretion and [Ca2+]cyt were in direct dependency of 
intraalveolar CO2 concentration. To elucidate whether the calcium shift from the cytosol to 
the mitochondria was responsible for the reduction of surfactant secretion during hypocapnia 
we first tested if surfactant secretion was promoted by calcium. Therefore, we intraalveolarly 
infused the intracellular Ca2+ chelator BAPTA-AM and repeated the measurement of LTG 
fluorescence intensity under hypercapnic conditions. We could show that the hypercapnia-
induced acceleration of surfactant secretion was blocked and the LTG fluorescence intensity 
values were similar to those under normocapnic conditions (figure 5C). Secondly, we 
pretreated the alveolar epithelial cells with the mitochondrial inhibitor rotenone. This 
procedure blocked the hypocapnia-induced reduction of surfactant secretion (figure 5C). 
Furthermore, the rate of surfactant secretion under these conditions was similar to that under 
control conditions (figure 5C).  
Hypocapnia reduces alveolar ventilation in situ. To elucidate the effect of hypocapnia-
induced reduction of the surfactant secretion on the alveolar ventilation we performed bright 
field microscopy of a specific lung area at baseline and two hours of exposition with 
normcapnia (40 mmHg pCO2) or hypocapnia (<10 mmHg pCO2). Hypocapnia reduced the 
projected alveolar area by 21% compared to their normocapnia state. In contrast, in rotenone- 
pretreated alveoli hypocapnia had no effect on the projected alveolar area (figure 5D and E).  
Ligature of pulmonary artery reduces surfactant protein D-secretion and alveolar 
surface in White New Zealand Rabbits in vivo. Intravital microscopy of the lung surface of 
volume-controlled ventilated rabbits revealed that following pulmonary artery ligation for 2 
hours the projected alveolar surface area decreased by about 30% . In contrast, inspiratory 
CO2 admixture inhibited this decrease of the projected alveolar surface area (figure 6A and 
B). In accordance with this observations surfactant protein D concentration in the BAL 
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decreased in lungs with ligated pulmonary arteries. This response was inhibited by 5% CO2 
ventilation (figure 6C and D). 
Ligature of pulmonary artery reduces the compliance und increase the inspiratory 
pressure and and the resistance and decreases the compliance in White New Zealand 
Rabbits in vivo. Ligation of pulmonal artery with consecutive intraalveolar hypocapnia 
induced an increase of the inspiratory pressure and the resistance and a decrease of the 
compliance vs. control in vivo (figure 6E-G). In contrast, all responses were inhibited by the 
inspiratory CO2 admixture of 5% (figure 6E-G). 
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Discussion 
We provide evidence that in isolated perfused rat lungs AEC sense changes in alveolar CO2 
concentration. When alveolar CO2 decreases, as seen in non-perfused but ventilated alveoli, 
AEC respond with a mitochondrially triggered reduction of [Ca2+]cyt and thus reductions in 
both LB exocytosis and alveolar ventilation (figure 7).  
Pulmonary gas exchange failure might be associated with characteristic changes of [CO2]iA. 
In non-ventilated but perfused lung districts [CO2]iA might rise whereas lung areas without 
perfusion but with ventilation [CO2]iA declines 19. Therefore, we hypothesized that in alveolar 
perfusion failure the drop in [CO2]iA provides the signal for AEC to reduce the alveolar 
ventilation in order to minimize ventilation/perfusion mismatch. 
CO2 sensing has been reported for plants and special types of neurons, as in brainstem and 
carotid body cells 7, 8. Recently, Vadász et al. reported that isolated AEC respond to high CO2 
levels with a Ca2+-dependent activation of AMP-activated protein kinase and thus endocytosis 
of Na,K-ATPase 20. However, the mechanism by which CO2 regulates Ca2+ signalling in AEC 
has not been elucidated so far.  
Using our established real-time imaging of intact alveoli we could confirm in situ that 
[Ca2+]cyt in AEC increases with elevated alveolar CO2 levels. Furthermore, a decrease of 
[CO2]iA induced a reduction of [Ca2+]cyt. The Ca2+ responses occurred in a direct relation to 
[CO2]iA within minutes in a totally reversible manner. The demonstration of CO2-induced 
Ca2+ signalling in AEC constitutes to our knowledge the first reported real-time imaging of 
pulmonary AEC in the intact lung. Since we were not able to keep the pH constant in the 
alveolar epithelial lining fluid of the isolated lung following changing [CO2]iA we measured 
[Ca2+]cyt in A549 cells under several conditions, in order to differentiate whether the Ca2+ 
responses in AEC were directly CO2 rather than pH mediated. First, changing the CO2 tension 
in the HEPES buffer from 40 to 0 or 80 mmHg and thus pH from 7.4 to 7.2 or 7.8, 
respectively, evoked a comparable [Ca2+]cyt response to the in situ situation. Second, changing 
the CO2 tension and keeping the pH constant at 7.4 induced the same [Ca2+]cyt response. 
Third, pH change from 7.4 to 7.8 alone did not alter [Ca2+]cyt. Furthermore, lowering CO2 
tension to 0 mmHg without additional pH buffering did not increase cytosolic pH. Taken 
together, these findings indicate that AEC sense CO2 independently from pH. 
To determine the underlying Ca2+-signalling mechanism, we considered the role of 
mitochondria, an important [Ca2+]cyt-modifying cell organelle. Using the model of the isolated 
lung, we could demonstrate that hypocapnia was accompanied not only by a decrease of 
[Ca2+]cyt but also by an increase of [Ca2+]mito. Its measurement was based on cationic rhod 2 
that accumulates in the anionic mitochondrial matrix. Cytosolic localisation could reduce the 
specifity for the determination of [Ca2+]mito. To keep this error small we co-localized the rhod 
2 fluorescence with the specific dye MTG. Furthermore, Ichimura and coworkers were able to 
demonstrate using a similar experimental setup that cell permeabilization revealed a quick 
release of the mainly cytosolic-localized fura 2 whereas the rhod 2 fluorescence stayed 
constant indicating that rhod 2 was mainly in the cytosol 21-24. In our case, hypocapnia 
induced a contrary change of [Ca2+] in the cytosol or in the mitochondria. Since we cannot 
completely exclude cytosolic localization of rhod 2 our determined [Ca2+]mito increase might 
therefore be underestimated. Additionally, we could show that the [Ca2+]cyt response was 
inhibited by the blockade of the mitochondrial Ca2+ uniporter with ruthenium red or the 
complex 1 with rotenone indicating a Ca2+ shift from the cytosol into mitochondria. The 
inhibitory effect of ruthenium red was less effective than of rotenone, which can be explained 
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by their different cell permeability characteristics. Summarizing these findings we suggest 
that hypocapnia induced a Ca2+ shift from the cytosol to the mitochondria.  
The decrease of [Ca2+]cyto following lowering [CO2]iA could also be explained by a Ca2+ shift 
into the extracellular space or  endoplasmic reticulum (ER). One could consider that rotenone, 
as a complex 1 inhibitor, might suppress ATP production and thus the Ca2+-ATPase 
dependent Ca2+ shift to the extracellular or ER compartment. Since, in contrast to rotenone, 
ruthenium red does not directly inhibit the respiratory chain and thus ATP production we 
believe that the inhibitory effect on the decrease of [Ca2+]cyto following hypocapnia was 
mainly due to an inhibition of mitochondrial Ca2+ uptake. Furthermore, the hypocapnia-
induced ER uptake of Ca2+ could be ruled out because fura 2ff ratio did not change after 
lowering CO2 (data not shown).  
The inhibition of the CO2-induced Ca2+ shift by rotenone further suggests that the driving 
force for the mitochondrial Ca2+ uptake was an increase of the respiratory chain activity and 
hence transmembrane potential. This hypothesis was confirmed by the finding that the 
fluorescence of TMRM, which accumulates in mitochondria in a potential-dependent manner, 
was enhanced in A549 cells under hypocapnic conditions compared to normocapnic 
conditions 25, 26. Addition of rotenone revealed a quick decrease of the TMRM fluorescence 
indicating that the respiratory chain activity is the important determinant of mitochondrial 
transmembrane potential. Further, hypocapnia induced an increase of the respiratory chain 
substrate NADH and the knockdown of isocitrate dehydrogenase, the NADH-producing 
Krebs cycle enzyme, inhibited the decrease of [Ca2+]cyto under low CO2 levels. The 
dependency of the respiratory chain activity from NADH has been demonstrated by 
Kuznetsov et al. 27.  Hence, in hypocapnia, NADH production and thus transmembrane 
potential, the driving force for the mitochondrial Ca2+ uptake, is increased. We therefore 
suggest that CO2, a byproduct of the Krebs cycle, inhibits Krebs cycle activity in a negative 
feedback loop. Under hypocapnic conditions, this inhibitory effect of CO2 on the Krebs cycle 
activity is reduced which subsequently increases NADH production and in turn the 
mitochondrial transmembrane potential. 
Under hypocapnic conditions, the [Ca2+]cyt decrease was associated with a reduction of LB 
secretion. In contrast, the hypercapnia-induced increase of [Ca2+]cyt was related to an increase 
in LB secretion. This response was completely blocked by the cytosolic Ca2+ chelator BAPTA 
indicating that CO2 regulates LB secretion in a Ca2+-dependent manner. Although Ca2+ 
independent exocytosis involving PKC- or cAMP-dependent mechanisms might occur, Ca2+ 
as a critical stimulus for LB secretion has been reported by several authors. For instance, 
Ichimura et al. demonstrated that Ca2+ uncaging stimulates LB secretion 4. Furthermore, in 
cultured Type 2 cells, an increase in [Ca2+]cyt induced by ionophores, cell stretch, or by 
secretagogues evoked surfactant secretion 5, 6. However, the role of CO2 on Ca2+-mediated LB 
secretion has so far not been elucidated. It has been reported that in lipopolysaccharide (LPS) 
treated Type 2 cells co-cultured with alveolar macrophages surfactant secretion did not 
change under hypercapnic conditions. Since surfactant responses to CO2 were not measured 
in the absence of LPS it is not clear whether CO2 was ineffective or the LPS inhibited a 
hypothetic CO2-mediated alteration in surfactant secretion 28. Shepard and colleagues 
measured the volumetric density of LB in response to CO2 in isolated and ventilated dog lungs 
29. The authors demonstrated that the LB density decreased at low CO2 tension. However, the 
responsible cellular processes in terms of LB synthesis, secretion and/or reabsorption were 
not determined. Other potential aspects are that CO2 might influence alveolar ventilation and 
that ventilation stimulates surfactant secretion 30. Therefore, it is not clear whether the LB 
density responses observed were due to CO2 or ventilation.    
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During hypocapnia rotenone blocked not only the Ca2+ shift from the cytosol to the 
mitochondria but also the inhibition of LB secretion. We therefore conclude that mitochondria 
regulate LB secretion by modifying [Ca2+]cyt in a CO2-dependent fashion because cytosolic 
Ca2+ chelation abolished LB secretion. Since rotenone had no effect on [Ca2+]cyt or on LB 
secretion under normocapnic conditions (data not shown) we rule out direct interference of 
rotenone with the LB secretion process. It is known that rotenone inhibits the mitochondrial 
membrane potential and thus ATP production. ATP as a paracrine mediator induces surfactant 
secretion by ligating purinergic receptors 31. In our experiments this mechanism, however, 
does not play a relevant role because LB secretion was enhanced and not inhibited following 
rotenone. ATP is also required for the endoplasmic Ca2+ uptake evoked by Ca2+ATPase. A 
potential influence of rotenone on LB secretion through inhibition of endoplasmic Ca2+ 
uptake is also unlikely because [Ca2+]cyt did not change after rotenone.  
Similar to LB secretion, the mean projected alveolar area decreased during hypocapnia and 
was also blocked by rotenone. Since surfactant reduces alveolar surface tension, it is likely 
that at constant alveolar pressure, as given in our experiments, the hypocapnia-induced 
reduction of the alveolar projected area was directly caused by the decrease of LB secretion. 
Tsang et al. showed in piglets that an acute pulmonary thrombembolism causes a 
compensatory ventilation shift out of non-perfused lung regions which is initiated by a 
hypocapnia-induced bronchoconstriction 19. We assume that in our model bronchoconstriction 
is not of significant relevance because rotenone, which was administered directly into to 
alveolus by bypassing the regarding bronchioli, inhibited the hypocapnia-induced reduction of 
the projected alveolar area. It is important to consider that the buffer in which rotenone is 
dissolved interacts with the alveolar lining fluid. Thus, alveoli from the comparison groups 
were also treated with the vehicle. However, the potential buffer-induced dilution of 
surfactant might counter the inhibitory effect of rotenone. We point out that our 
interpretations are limited to a two-dimensional analysis of a three-dimensional alveolar 
geometry. Nevertheless, assuming a spherical shape of alveoli changes of the projected area 
would be signify even higher changes in alveolar volume. Therefore, the measurement of the 
projected alveolar area might underrepresent the alveolar ventilation. Taken together, our 
findings provide the first evidence that mitochondria regulate LB secretion and thus alveolar 
ventilation in a CO2-dependent manner.  
To test whether the hypocapnia-induced reduction of LB secretion and as a consequence 
alveolar ventilation is a relevant mechanism in alveolar perfusion failure in order to minimize 
ventilation/perfusion mismatch, we carried out in vivo experiments with intravital lung 
microscopy and pulmonary artery ligature. In accordance with the in situ findings the 
occlusion of the pulmonary artery resulted in a decrease of the projected alveolar area 
indicating a reduction of ventilation in the non-perfused lung area. This finding confirms 
reports by several authors. Bruns and Sauerbruch were probably the first who in 1911 
described that the ligature of a pulmonary artery branch in dogs resulted in a collapse of the 
corresponding pulmonary lobe 32. In 2009 Tsang et al. reported that alteration of regional CO2 
tension correlates with the changes of regional ventilation 19. As described above, the authors 
considered that a hypocapnia-induced bronchoconstriction was responsible for the ventilation 
reduction. We cannot exclude this mechanism in our experiments. However, we found that 
the decrease in alveolar ventilation following pulmonary artery ligature was accompanied by 
a reduction of the surfactant protein concentration in the BAL and that these responses were 
inhibited by adding CO2 into the inspired gas.  Since surfactant reduces alveolar surface 
tension we conclude that this mechanism plays at least a partial role in adapting ventilation to 
changes in perfusion. 
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In summary, we identify a novel CO2-sensing mechanism of AEC in which mitochondria play 
a key role. The functional consequence is a Ca2+-mediated regulation of LB secretion. We 
conclude that this mechanism regulates the reduction of ventilation in lung areas with 
perfusion failure in order to reduce ventilation/perfusion mismatch and thus optimize gas 
exchange. 
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Figure legends 
 
Figure 1.  [Ca2+]cyt in alveolar epithelial cells in situ. (A) Images of a single intact alveolus show 
the pseudocolor-coded 340:380 ratio for fura 2-loaded alveolar epithelial cells normocapnic 
([CO2]iA: 5 Vol%), hypocapnic ([CO2]iA: 0 Vol%), and hypercapnic ([CO2]iA: 10 Vol%) 
conditions. Alveolar septum is indicated (arrows). (B) Tracing of [Ca2+]cyt (gray) and the 
mean value (black) of the respective oscillation minimum and maximum from an identical 
epithelial cell under normo-, hypo and hypercapnic conditions. Intraalveolar hypocapnia 
reduces [Ca2+]cyt by 40 nM whereas hypercapnia increases [Ca2+]cyt by 45 nM in situ. 
Regarding [CO2]iA were as indicated. (C) Group data of [Ca2+]cyt-responses 15 minutes 
following onset of hypo- or hypercapnic conditions with [CO2]iA of 0 or 10 Vol% CO2, 
respectively. Mean±SE, # p<0.05 vs. [CO2]iA of 5 Vol%. Repeated 5 times. (D) Alveolar 
microinjection the mitochondrial inhibitors ruthenium red or rotenone inhibited the 
hypocapnic ([CO2]iA: 0 Vol%)-induced reduction of [Ca2+]cyt by 50 or 100%, respectively, in 
situ. Mean±SE, # p<0.05 vs. 5 Vol% [CO2]iA. Repeated 5 times. 
 
Figure 2. [Ca2+]mito in alveolar epithelial cells in situ. (A) Images show the identical alveolus 
loaded with the specific mitochondrial dye MTG (green fluorescence) in combination with the 
calcium sensitive dye rhod 2 (red fluorescence) and the computer-generated co-localization of 
both dyes (yellow). Arrows indicate mitochondria. Dotted lines are alveolar margins as 
detected in bright-field images obtained in parallel. (B) Group data analysis of rhod 2 
fluorescence in AEC of an intact alveolus under normo- and hypocapnic conditions ([CO2]iA 
of 5 or 0 Vol%, respectively), mean ± SE, n=6.  
 
Figure 3. [Ca2+]cyt-response to CO2 in dependence of pH in vitro. (A) Tracing of [Ca2+]cyt in 
A549 cells under normo- and hypocapnic conditions. Black blot: the pH of the superfusion 
buffer was 7.4 under normocapnic conditions and increased to 7.8 under hypocapnic 
conditions.  Red blot: the pH of the superfusion buffer was kept constant at 7.4 even under 
hypocapnic conditions. (B) Bars show group data of [Ca2+]cyt in A549 cells for indicated 
superfusion conditions. Hypocapnia induced a reduction of [Ca2+]cyt under constant 
extracellular pH of 7.4, whereas a change of extracellular pH from 7.4 to 7.8 did not change 
[Ca2+]cyt under normocapnic conditions in vitro. Mean±SE, # p<0.05 vs. baseline. Repeated 8 
times. (C) Cytosolic pH calibration: cytosolic 500:450 ratio for BCECF-loaded A549 cells 
treated with 0.005% saponin for 1 minute followed by superfusion with buffer at given pH 
values. Mean±SE, r = 0.47, repeated twice. (D) Cytosolic pH in BCECF-loaded A549 cells 
under normo- or hypocapnic conditions, as indicated. Extracellular pH changed from 7.4 
under normocapnic to 7.8 under hypocapnic conditions. Repeated 7 times. 
Figure 4. [Ca2+]cyt, [Ca2+]mito, NADH, and ΔΨ in alveolar epithelial cells in situ. (A) Tracing of 
the ratio between mitochondrial and cytosolic TMRM fluorescence intensity of native, 
scrambled siRNA- or IDH3G- siRNA-treated A549 cells under normo- or hypocapnic 
conditions at constant pH of 7.4, as indicated. (B) Group data of the TMRM ratio response 15 
minutes following onset of hypocapnic conditions in native, scrambled siRNA- or IDH3G-
siRNA-treated A549 cells at constant extracellular pH of 7.4, respectively. Mean±SE, # 
p<0.05 vs. baseline, * p<0.05 vs. native A549 cells. Repeated 4-6 times. (C) Tracing of the 
mitochondrial and cytosolic TMRM fluorescence intensity and the ratio between both of 
native, scrambled siRNA- or IDH3G- siRNA-treated A549 cells under normo- or hypocapnic 
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conditions, as indicated. Experiments were performed at constant extracellular pH of 7.4, 
respectively. Timepoint of rotenone application is marked by the arrow. (D) Group data of the 
TMRM ratio in native A549 cells before and after rotenone application, each under 
normocapnic condition, and after rotenone under hypocapnic conditions. Experiments were 
performed at constant extracellular pH of 7.4, respectively. Mean±SE, # p<0.05 vs. 
normocapnia without rotenone. Repeated 5 times. (E) Gels show RT-PCR products for 
IDH3G- and GAPDH-mRNA in native (lane 2 and 3), in IDH3G siRNA- (lane 4 and 5), and 
scrambled siRNA-treated (lane 6 and 7 A549 cells. Lane 1 and 8: molecular weight ladder. 
(F) Group data of [Ca2+]cyt-responses 10 minutes following onset of hypocapnic conditions at 
constant extracellular pH of 7.4 in native, scrambled siRNA- or IDH3G-siRNA-treated A549 
cells. Mean±SE, * p<0.05 vs. native A549 cells, § p<0.05 vs. scrambles siRNA-treated A549 
cells. Repeated 6 times. (G) Tracing of rhod 2 fluorescence of native, scrambled siRNA- or 
IDH3G- siRNA-treated A549 cells under normo- or hypocapnic conditions, as indicated. 
Experiments were performed at constant extracellular pH of 7.4, respectively. (H) Group data 
of rhod 2 fluorescence response 10 minutes following onset of hypocapnic conditions in 
native, scrambled siRNA- or IDH3G-siRNA-treated A549 cells. Experiments were performed 
at constant extracellular pH of 7.4, respectively. Mean±SE, * p<0.05 vs. native A549 cells, § 
p<0.05 vs. scrambles siRNA-treated A549 cells. Repeated 6 times. (I) Group data of NADH-
concentration measured by a NADH-assay in native A549 under normocapnic conditions, 
hypocapnic conditions and after rotenone under hypocapnic conditions at constant 
extracellular pH of 7.4, respectively. Mean±SE, * p<0.05 vs. normocapnia, § p<0.05 vs. 
hypocapnia alone. Repeated 8 times. (J) Tracing of rhod 2 fluorescence of native or IDH3G-
siRNA-treated A549 cells under normo- or hypocapnic conditions, as indicated. Rotenone 
was applicated after baseline in both groups. Experiments were performed at constant 
extracellular pH of 7.4, respectively. (K) Group data of NADH response 10 minutes 
following rotenone alone and 10 minutes following rotenone in combination with hypocapnic 
conditions in native or IDH3G-siRNA-treated A549 cells. Experiments were performed at 
constant extracellular pH of 7.4, respectively. Mean±SE, # p<0.05 vs. baseline. Repeated 6 
times.  
 
Figure 5. Surfactant secretion in AEC in situ. (A) Image shows an LTG-loaded alveolus.   
Arrows indicate lamellar bodies from alveolar Type 2 cells. Dotted lines are alveolar margins 
as detected in bright-field images obtained in parallel. (B) Color-coded images of a single 
alveolar type II cell after alveolar microinjection of LysoTracker Green (LTG). Pictures were 
taken under baseline conditions with an alveolar CO2 concentration of 5 Vol% and 20 minutes 
after switching to 0 or 10 Vol% or staying at 5 Vol%. (C) Time dependency of LTG-intensity. 
Data are mean±SE. LTG-intensity decreases equivalent to constant surfactant secretion under 
normocapnic conditions. Hypocapnia induces an inhibition of the surfactant secretion, 
whereas hypercapnia increases the surfactant secretion in situ. Hypocapnia-induced reduction 
of surfactant secretion is blocked by rotenone microinjected into the alveolus. Hypercapnia- 
induced elevation of surfactant secretion is blocked by BAPTA microinjected into the 
alveolus. * p<0.05 vs. 5 Vol% [CO2]iA. Repeated 6 times. (D) Brightfield image of the 
isolated lung surface under baseline conditions and 120 min after intervention as indicated. 
(E) Hypocapnia of 0 Vol% [CO2]iA reduces the projected alveolar area up to about 21% vs. 5 
Vol% [CO2]iA after 2 hours of exposition in situ. Hypocapnia has no effect on the projected 
alveolar area in rotenone-pretreated alveoli. Data are mean±SE. # p<0.05 vs. 5 Vol% [CO2]iA. 
Repeated 6 times. 
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Figure 6. Ventilation after plmonary artery ligation in vivo. (A) Intravital brightfield image of 
the lung surface. Microscopy was performed through a thoracic window implanted into the 
left chest wall of a rabbit. Pictures were taken under baseline conditions and 120 minutes 
following sham dissection (control) or ligation of the ipsilateral pulmonary artery with or 
without 5 Vol% CO2 insufflation. (B) Group data of the projected alveolar perimeter under 
baseline conditions and 120 minutes following sham dissection (control) or ligation of the 
ipsilateral pulmonary artery (PA-ligation) without or with 5 Vol% CO2 insufflation. Data are 
means±SE, * p<0.05 vs. control, § p<0.05 vs. PA-ligation+CO2. Repeated 4 times. (C) 
Representative Western blot of SP-D in rabbit BAL. Lane 1: molecular weight ladder, lane 2 
and 3: control, lane 4: PA-ligature, lane 5 and 6: CO2 insufflation + PA-ligature. (D) 
Groupdata analysis of SP-D density, data are means ± SEM. * p < 0.05% vs. sham. (E-G) 
Groupdata analysis of pinsp, resistance or compliance under baseline conditions and 120 
minutes following sham dissection (control) or ligation of the ipsilateral pulmonary artery 
with or without CO2 insufflation. Data are means ± SEM. * p < 0.05% vs. control, § p < 0.05 
vs. PA-ligature + 5 Vol% CO2. Repeated 4 times. 
 
Figure 7. (A) Pulmonary perfusion failure leads to a decrease of [CO2]iA. This [CO2]iA drop is 
sensed by alveolar epithelial cells resulting in a reduction of alveolar ventilation and thus 
ventilation/perfusion mismatch. (B) Sequence of events underlying Ca2+ dependent [CO2]iA 
sensing mechanism. Alveolar perfusion failure leads to alveolar hypocapnia (I). Alveolar 
hypocapnia induced activation of Krebs cycle via a feedback mechanism (II). Krebs cycle 
activation induces via an increase of NADH (III) an elevation of ∆Ψ (IV) with following 
calcium shift from cytosol into the mitochondrium (V). Decrease of [Ca2+]cyt results in a 
reduction of Ca2+ dependent surfactant secretion (VI). 
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Methods 
Animals. Male Sprague Dawley rats (350g) and White New Zealand rabbits (2.5 kg) were 
purchased from Charles River (Sulzfeld, Germany) (see supplementary methods for details).  
 
Materials. Fura 2-AM, LysoTracker green (LTG), MitoTracker green (MTG), rhod 2, 
BCECF-AM (2´, 7`-bis-(2-carboxylmethyl)-5-(and 6-) carboxyfluorescin-AM) and TMRM 
(tetramethylrhodamine methyl ester) were purchased from Molecular probes (Invitrogen, 
Karlsruhe, Germany). Rotenone, ruthenium red and BAPTA-AM (1, 2-bis-(2-
aminophenoxy)-ethane-N, N, N´,N´-tetraacetic acid tetrakis-(acetoxymethylester)) were 
purchased from Sigma-Aldrich (Germany). Vehicle for dyes and other agents was HEPES 
buffer (150 mmol/l Na+, 5 mmol/l K+, 1.0 mmol/l Ca2+, 1 mmol/l Mg2+,  and 20 mmol/l 
HEPES at pH 7.4) containing 4% dextran (70 kDa) and 1% FBS at pH 7.4 and osmolarity of 
295 mosm. All esterified fluorescent probes were prepared as stock solutions in 
dimethylsulfoxide (DMSO). 
 
In situ experiments 
Lung preparation. Using the previously reported method, lungs were isolated from Sprague-
Dawley rats (anesthetized with 1.2 Vol% isoflurane and intraperitoneal injection of 100 
mg/kg ketamine and 20 mg/kg xylazinum (rompun™)), and perfused with autologous blood 
(14ml/min) at 37°C 33, 34. Lungs were constantly inflated through an airway cannula with an 
airway pressure of 5 cmH2O with a normocapnic gas mixture of 30% O2, 5% CO2, and 65% 
N2 under baseline conditions. Pulmonary artery and left atrial (PLA) pressures were held at 10 
and 2 cmH2O, respectively. 
Alveolar micropuncture. We gave intraalveolar injections by alveolar micropuncture 
according to previously reported methods 4, 34,35 (see supplementary for details).  
Hypocapnia/hypercapnia induction. Switching the inflation gas to a hypocapnic (30% O2, 
0% CO2 and, 70% N2) or hypercapnic (30% O2, 10% CO2 and, 60% N2) mixture altered the 
pCO2 of the venous blood to hypocapnic values from 36.8±6.5 to 6.6±2.3 mmHg or to 
79.6±3.6 mmHg, respectively. Blood pO2 was constant throughout (215±34 mmHg). To 
prevent CO2-diffusion to the ambient air across the exposed lung surface, we covered the 
lungs with gas-tight plastic. 
Real-time lung imaging. Using an epifluorescence microscope (Axiotech, Zeiss, Göttingen, 
Germany) fluorophores were excited using appropriate interference filters and filter sets 
(Semrock, Rochester, USA) (see supplementary methods for details).  
Alveolar [Ca2+]cyt  and [Ca2+]mito determinations. Our methods for [Ca2+]cyt  and [Ca2+]mito 
quantification were previously described 34, 36-38. Briefly, we quantified [Ca2+]cyt in alveolar  
epithelial cells by the fura 2 method after alveolar microinjection of fura 2-AM for 30 min.  
To detect [Ca2+]mito we microinjected rhod 2-AM into an alveolus for 15min followed by a 
Ringer´s flush (see supplementary methods for details).   
Alveolar Type II cell exocytosis of surfactant. To determine surfactant secretion in situ, we 
imaged single alveolar cells from isolated blood-perfused rat lung through the loss of cell 
fluorescence of intraalveolar microinjected LysoTracker Green (LTG) 35.  
Measurement of alveolar projected area. To measure the influence of altered surfactant 
secretion through hypocapnia ([CO2]iA <10mmHg), we took light microscopy pictures of the 
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lung surface with 20x amplification and measured the size of the projected alveolar area by 
using the software Metamorph (Molecular Device; Downington, PA, USA). 
Experimental protocol. [Ca2+]cyt, [Ca2+]mito, surfactant secretion, and alveolar projected area 
were measured under normocapnic and hypocapnic conditions. To identify the supposed key 
role of the mitochondria, we microinjected ruthenium red or rotenone and repeated the 
measurement of [Ca2+]cyt, [Ca2+]mito, surfactant secretion, and alveolar projected area under 
normocapnic and hypocapnic conditions in an additional set of experiments. To elucidate the 
Ca2+-dependency of surfactant secretion, the membrane-permeating Ca2+ chelator BAPTA-
AM in Ca2+-free buffer (150 mmol/l Na+, 5 mmol/l K+, 1 mmol/l Mg2+, and 20 mmol/l 
HEPES at pH 7.4) was microinjected and surfactant secretion, and alveolar projected area was 
determined under normocapnic and hypocapnic conditions. 
 
In vitro experiments 
Cell culture. Human lung carcinoma A549 cells with type 2 cell characteristics were grown 
in F-12K Medium (ATCC, Mahassa, VA, USA). This cell type has been widely used as a 
model to study the response of AEC in several conditions 39, 40 (see supplementary methods 
for details).  
Real-time cell imaging. For fluorescent imaging of fluorophore-loaded cells an 
epifluorescence microscope (Olympus, Germany) was used (see supplementary methods for 
details). 
[Ca2+]cyt  determinations. For [Ca2+]cyt measurements, cells were loaded for 45 minutes with 
10 μM fura-2-AM. Fluorescence images were recorded under normo- or hypocapnic 
conditions in combination with an extracellular pH of 7.4 or 7.8 at 10 seconds intervals (see 
supplementary methods for details).   
Cytosolic pH measurement. Cells were loaded with the acetoxymethyl esters of BCECF (5 
mM) 41. Cytosolic pH was measured after induction of hypocapnia (<10 mmHg pCO2) (see 
supplementary methods for details). 
Mitochondrial membrane potential measurement. For mitochondrial membrane potential 
assessment, A549 cells were loaded with tetramethylrhodamine methyl ester (TMRM). This 
indicator dye is a lipophilic cation accumulated by mitochondria in proportion to the electrical 
potential across their inner membrane (Δψ) 42. The wavelength for excitation was 560 nm 
while monitoring the emission at 590 nm. Addition of the mitochondrial depolarizer FCCP 
(50 nM) resulted in a rapid loss of the mitochondrial TMRM fluorescence. 
Mitochondrial NADH production. NADH concentration was quantified by measuring its 
autofluorescence intensity. A549 were excitated with 360 nm while monitoring the emission 
at 510 nm. For proofing the mitochondrial production of NADH, its autofluorescence was co-
localized with the mitochondria specific marker MTG.  
Biochemical determination of NADH concentration. The NADH concentrations in cells 
are measured using the ultrasensitive EnzyChrom TM NAD+/NADH Assay Kit from 
BioAssay Systems (Hayward, CA, USA) (see supplementary methods for details).   
Isocitrate dehydrogenase 3 (NAD+) gamma (IDH3G) knockdown. A549 cells were 
transfected with 10 nM stealth siRNA of IDH3G (Invitrogen and control (scrambled) stealth 
siRNA (Invitrogen) by using Lipofectamine RNAIMAX (Invitrogen) according to the 
manufacturer’s protocol (see supplementary methods for details). 
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Reverse transcriptase polymerase chain reaction (RT-PCR). (see supplementary methods 
for details).   
 
In-vivo experiments 
Lung preparations. White male New Zealand rabbits were anesthetized by intravenous 
application of midazolam (0.1 mg/kg), fentanyl (5 μg/kg) and pancuronium bromide (0.3 
mg/kg bw). The surgical preparation and experimental setup have previously been described 
in detail 43, 44 (see supplementary methods for details). 
Intravital microscopy. Subpleural alveoli were sequentially visualized under a fluorescence 
microscope (Zeiss, Axiotech, Germany) during prolonged inspiration periods of 10 seconds. 
For video recordings a CCD camera (Photometrics Coolsnap HQ2, USA) and Metamorph 
software (Molecular Device; Downington, PA, USA) were used. 
Measurement of alveolar projected area. To measure the influence of altered surfactant 
secretion through hypocapnia we took light microscopy pictures of the lung surface with 20x 
amplification and measured the size of the projected alveolar area by using the software 
Metamorph (Molecular Device; Downington, PA, USA). 
Experimental protocol. The rabbits were randomized into three groups: 1. control without 
pulmonal artery ligature (control-group), 2. pulmonal artery ligature (PA-ligature group), 3. 
pulmonal artery ligature with inspiratory application of CO2 (therapy-group). Compliance, 
resistance and inspiratory pressure were measured by the respirator (Zeus®, Dräger, Lübeck, 
Germany) and changes in projected alveolar area were visualized by light microscopy at 
baseline and after 120 minutes. At the end of videomicroscopy the animals were sacrificed 
and the lungs were lavaged for the measurement of the surfactant protein A-fraction by 
westernblotting. 
Western blot. (see supplementary methods for details). 
Statistics 
All data are represented as means ± SE. Statistical data analysis was performed using 
SigmaStat (Systat Software, USA). Comparisons between the groups were tested using 
ANOVA on ranks followed by a pairwise multiple comparison. Repeated measurements were 
tested using the Mann-Whitney Rank Sum Test. Statistical significance was accepted at 
p<0.05. 
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